This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Wang Wang - Innovator in mRNA Vaccine Development
Introduction
Wang Wang is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of vaccine development, particularly focusing on respiratory syncytial virus (RSV). His innovative work has the potential to impact public health positively.
Latest Patents
Wang Wang holds a patent for a "Respiratory Syncytial Virus mRNA Vaccine, and Preparation Method Therefor and Use Thereof." This patent represents a crucial advancement in the fight against RSV, which is a common cause of respiratory infections in infants and young children. He has 1 patent to his name, showcasing his dedication to innovation in the pharmaceutical industry.
Career Highlights
Wang Wang is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His role at the company allows him to work on cutting-edge research and development projects. His expertise in mRNA technology positions him as a key player in the ongoing efforts to create effective vaccines.
Collaborations
Wang collaborates with talented colleagues, including Gengshen Song and Kai Dong. Together, they contribute to the advancement of medical science and the development of new therapeutic solutions.
Conclusion
Wang Wang's work in mRNA vaccine development exemplifies the spirit of innovation in the pharmaceutical industry. His contributions are vital in addressing public health challenges, particularly in combating respiratory infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile